Mastoiditis

01Pathophysiology

Mastoiditis is fundamentally a complication of acute otitis media and represents the most common intracranial complication of middle ear infection. The mastoid bone, located posterior to the ear, contains a network of air cells that communicate directly with the middle ear cavity through the aditus ad antrum. This anatomical connection is the reason middle ear infections can extend posteriorly into the mastoid.

When AOM is inadequately treated or particularly virulent, bacteria migrate from the middle ear into the mastoid air cells, producing acute mastoiditis. In the early phase, there is mucosal inflammation and accumulation of purulent material within the air cells. If the infection progresses, the thin bony septae between the mastoid air cells begin to demineralize and erode under the pressure of pus and the osteoclastic activity driven by inflammatory mediators. This stage is called coalescent mastoiditis and marks the transition from a mucosal process to an osteitic one.

This bony destruction explains why patients develop postauricular swelling and tenderness: the infection erodes through the lateral cortex of the mastoid bone, forming a subperiosteal abscess that pushes the auricle outward and downward. The loss of the postauricular crease is a direct consequence of this swelling.

Because the mastoid is anatomically close to several critical structures, untreated mastoiditis can lead to dangerous complications. Erosion medially can reach the sigmoid sinus, causing septic thrombosis. Extension superiorly through the tegmen tympani can cause an epidural abscess or meningitis. Tracking of infection along the medial aspect of the mastoid tip into the digastric groove can lead to a deep neck abscess known as a Bezold abscess, which presents as a neck mass along the sternocleidomastoid muscle.

02Classification and Clinical Manifestation

Complications by Anatomical Spread

03Diagnostic Workup

The diagnosis of mastoiditis is primarily clinical, based on the combination of recent or ongoing AOM with the characteristic postauricular findings. However, imaging is essential to confirm the diagnosis and assess the extent of disease.

CT of the temporal bone with IV contrast is the imaging study of choice and should be obtained promptly when mastoiditis is suspected. The hallmark finding is coalescence of mastoid air cells with destruction of the bony septae. Simple opacification of the air cells alone is not diagnostic, as this can be seen with uncomplicated AOM. What distinguishes mastoiditis on CT is the loss of the normal bony architecture combined with abscess formation. If a subperiosteal abscess is present, CT will show a rim-enhancing fluid collection between the mastoid cortex and the overlying periosteum.

If there is clinical concern for intracranial extension (altered mental status, focal neurological deficits, high spiking fevers, papilledema), MRI with contrast should be added. MRI is superior to CT for detecting epidural or subdural collections and for evaluating sigmoid sinus thrombosis. MR venography or CT venography can confirm sinus thrombosis when suspected.

Laboratory studies serve a supportive role. Leukocytosis and elevated CRP help gauge the severity of the infection and monitor treatment response. Blood cultures should be drawn before starting IV antibiotics, particularly in patients who appear septic. Tympanocentesis or culture from myringotomy provides the most reliable specimen for identifying the causative organism and is especially valuable when empiric therapy fails.

04Management and Treatment

Acute Stabilization

All patients with mastoiditis require hospital admission and intravenous antibiotics. Empiric regimens must cover the common pathogens including resistant pneumococcus and staphylococcal species. A standard approach is:

Vancomycin (15 mg/kg IV every 6 hours in children; 15-20 mg/kg IV every 8-12 hours in adults, targeting trough levels of 15-20 mcg/mL) plus ceftriaxone (50-100 mg/kg/day IV divided every 12-24 hours in children; 2 g IV every 12-24 hours in adults). If Pseudomonas is a concern (chronic otitis media, immunocompromised host), cefepime (50 mg/kg IV every 8 hours in children) or piperacillin-tazobactam should replace ceftriaxone.

Antibiotic therapy is then narrowed based on culture results. Total antibiotic duration is typically 3-4 weeks, with a transition to oral therapy once there is clear clinical improvement (resolution of fever, decreasing swelling, improving labs), usually after at least 7-10 days of IV therapy.

Myringotomy with tympanostomy tube insertion is performed early to drain the middle ear, obtain culture material, and decompress the system. This is considered part of the initial management in nearly all cases.

Surgical Management

If there is a subperiosteal abscess, surgical drainage with cortical mastoidectomy is indicated and should not be delayed. Cortical mastoidectomy involves removing the diseased mastoid air cells while preserving the ear canal wall and the ossicular chain. This procedure both drains the infection and removes necrotic bone that perpetuates it.

If a patient fails to improve clinically after 48-72 hours of appropriate IV antibiotics and myringotomy, mastoidectomy should be pursued even in the absence of a clear abscess on imaging. Persistent fever, worsening postauricular swelling, or rising inflammatory markers all signal inadequate source control.

For intracranial complications, management is multidisciplinary. Sigmoid sinus thrombosis may warrant anticoagulation with heparin, though this remains somewhat controversial and is decided case by case. Epidural or subdural abscesses require neurosurgical drainage.

05Differential Diagnosis and Distractors

06Traps and High-Yield Pearls

The single most common way students lose points on mastoiditis questions is by confusing simple AOM with mastoiditis. A vignette describing a child with fever and ear pain after recent AOM is intentionally designed to test whether you recognize the transition from otitis media to mastoiditis. The discriminating feature is always the postauricular findings: swelling, erythema, tenderness, and displacement of the pinna outward and downward. If these signs are absent, the answer is not mastoiditis regardless of how sick the child appears.

Another frequent trap involves the imaging interpretation. Students see "opacified mastoid air cells" on CT and immediately select mastoiditis. However, simple fluid in the mastoid air cells is an expected finding in uncomplicated AOM. The CT finding that confirms coalescent mastoiditis is destruction of the bony septae, not merely opacification. Always look for this distinction in the question stem.

On management questions, the test often presents a child with mastoiditis who is already on IV antibiotics but not improving after 48-72 hours. The "next best step" in this scenario is mastoidectomy, not switching antibiotics. Students who reflexively choose broader antibiotic coverage will be penalized. Source control is the priority when medical therapy fails.

Finally, be alert for complication-recognition questions. A patient with mastoiditis who develops a swelling along the SCM muscle points to Bezold abscess. A patient with mastoiditis who develops spiking fevers, headache, and papilledema points to sigmoid sinus thrombosis. These complications are tested because they require the student to connect the anatomical relationships of the mastoid bone to surrounding structures, which is the core competency being evaluated.